EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa

Valerie R Stichert iD, Nichole Halliburton, Sarah Crawford, Jennifer Phillips, Kalyani S Marathe iD, Beth A Moeves

Pediatric Dermatology · 25.06.2026

DOI: 10.1111/pde.70307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, online erschienen am 25.06.2026. Verfasst von Valerie R Stichert und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives Recessive dystrophic epidermolysis bullosa inversa (RDEB‐I) is a rare subtype of dystrophic epidermolysis bullosa (EB) characterized by intertriginous cutaneous involvement and frequent mucosal disease. Although mucosal involvement is recognized in RDEB‐I, its cumulative clinical burden remains poorly defined. This study systematically describes mucosal involvement, related complications, and procedural interventions in patients with RDEB‐I.

Methods

We performed a retrospective chart review of patients with RDEB‐I followed at a multidisciplinary EB center. Records were reviewed to document mucosal involvement across organ systems, associated complications, procedural interventions, and COL7A1 variants.

Results

Ten patients were included (mean age at latest follow‐up 32.5 years, range 9–54; 70% female). Mucosal involvement was universal, with oral, esophageal, and anorectal disease present in all patients (10/10), and frequent otologic (8/10), genitourinary (7/10), and ocular (4/10) involvement. Patients developed multiple mucosal complications (mean 13.2 per patient; range 8–22), requiring numerous procedures (mean 12.4 per patient; range 2–30). All involved systems except ocular required procedural intervention, most commonly for esophageal disease, including 74 dilations across 9 patients. Procedural complications occurred in 6 patients, including 10 esophageal mucosal injuries during dilation, as well as corneal abrasions and oropharyngeal injury from anesthetic management. Among patients with available genetic data (9/10), all harbored at least one variant that is either a glycine or arginine substitution in COL7A1 .

Conclusions

Mucosal disease is a defining feature of RDEB‐I, contributing substantially to morbidity and procedural burden across organ systems. Recognition of multisystem mucosal involvement is essential for anticipatory guidance and accurate disease severity assessment.

Schlagwörter

Stichwörter der Autor:innen

dystrophic epidermolysis bullosaepidermolysis bullosaesophageal dilationinversa phenotypemucosal disease

Autor:innen und Institutionen

  • University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Division of Dermatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

ORCID-Profile: Valerie R Stichert, Kalyani S Marathe

Zitieren

APA

Stichert, V. R., Halliburton, N., Crawford, S., Phillips, J., Marathe, K. S., & Moeves, B. A. (2026). Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa. Pediatric Dermatology. https://doi.org/10.1111/pde.70307

Vancouver

Stichert VR, Halliburton N, Crawford S, Phillips J, Marathe KS, Moeves BA. Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa. Pediatric Dermatology. 2026. doi:10.1111/pde.70307

BibTeX
@article{Stichert2026,
  author = {Stichert, Valerie R and Halliburton, Nichole and Crawford, Sarah and Phillips, Jennifer and Marathe, Kalyani S and Moeves, Beth A},
  title = {Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa},
  journal = {Pediatric Dermatology},
  year = {2026},
  doi = {10.1111/pde.70307}
}
Kostenlos starten →